CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 291,049	$ 201,525
Accounts receivable	9,401	0
Receivables from collaboration arrangements	54,672	110,711
Inventory	55,897	0
Prepaid expenses	29,559	1,367
Other current assets	2,933	70
Total current assets	443,511	313,673
Property and equipment, net	170	12
Equity and long-term investments	403,013	483,845
Capitalized fees paid, net	97,607	111,430
Right-of-use assets	3,265	97
Goodwill	26,713	0
Intangible assets	252,919	0
Deferred tax assets, net	0	17,327
Other assets	4,299	11
Total assets	1,231,497	926,395
Current liabilities:
Accounts payable	2,939	27
Accrued personnel-related expenses	8,022	619
Accrued interest payable	4,359	4,152
Deferred revenue	2,094	0
Convertible subordinated notes due 2023, net of issuance costs	96,193	0
Income tax payable	154	0
Other accrued liabilities	21,207	1,009
Total current liabilities	134,968	5,807
Long-term debt, net of discount and issuance costs	444,180	394,653
Other long-term liabilities	70,918	0
Deferred tax liabilities, net	5,771	0
Income tax payable, long-term	9,872	0
Commitments and contingencies (Note 13)
Stockholders' equity:
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding	0	0
Common stock: $0.01 par value, 200,000 shares authorized, 69,188 and 69,566 issued and outstanding as of December 31, 2022 and December 31, 2021 respectively	692	696
Treasury stock: at cost, 32,005 shares as of December 31, 2022 and December 31, 2021	(393,829)	(393,829)
Additional paid-in capital	1,163,836	1,264,024
Accumulated deficit	(204,911)	(456,148)
Total Innoviva stockholders' equity	565,788	414,743
Noncontrolling interests	0	111,192
Total stockholders' equity	565,788	525,935
Total liabilities and stockholders' equity	$ 1,231,497	$ 926,395